P53 gene alterations and protein accumulation in colorectal cancer

Journal of Clinical Pathology - Clinical Molecular Pathology

Volumn 49, Issue 2, 1996, Pages

  Bertorelle, R ^a   Esposito, G ^a   Belluco, C ^b   Bonaldi, L ^a   Del Mistro, A ^b   Nitti, D ^a   Lise, M ^a   Chieco Bianchi, L ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Istituto di Oncologia   (Italy)

Author keywords

Colorectal cancer; Immunohistochemistry; p53; PCR SSCP

Indexed keywords

PROTEIN P53;

ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0029928936     PISSN: 13552910     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.49.2.m85     Document Type: Article

References (42)

1. Hollstein M, Sidransky D, Vogelstein B, Harris CG. p53 mutations in human cancers. Science 1991;253:49-53.
2. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig R. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-11.
3. Prokocimer M, Rotter V. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hématologie cell lineages. Blood I994;84: 2391-411.
4. Sarnow P, Ho YSH, Williams J, Levine AJ. Adenovirus Elb58 kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 1982;28:387-94.
5. Wynford-Thomas D. p53 in tumor pathology: can we trust immunocytochemistry? J Pathol 1992;166:329-30.
6. Hall PA, Lane DP. p53 in tumor pathology: can we trust immunohistochemistry?-Revisited! J Pathol 1994;172: 1-4.
7. Orita M, Suzuky Y, Sekita T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;S: 874-9.
8. Cripps KJ, Purdie CA, Carder PJ, White S, Komine K, Bird CC, et al. A study of stabilisation of p53 protein versus point mutation in colorectal carcinoma. Oncogene 1994;9:2739-43.
9. Dix B, Robbins P, Carrelle S, House A, lacopetta B. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer 1994;70:585-90.
10. Cordon-Cardo C, Dalbagni G, Saez GT, Oliva MR, Zhang Z-F, Rosai J, et al. p53 mutations in human bladder cancer: genotypic versus phenotypic patterns. Int J Cancer 1994; 56:347-53.
11. Esrig D, Spruk CH III, Nichols PW, Chaiwun B, Steven K, Groshen S, et al. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 1993;143:138997.
12. Umekita Y, Kobayashi K, Saheki T, Yoshida H. Nuclear accumulation of p53 protein correlates with mutations in the p53 gene on archival paraffin-embedded tissues of human breast cancer. Jpn J Cancer Res 1994;85:825-30.
13. Allred DC, Clark GM, Elledge R, Fuqua SAW, Brown RW, Chamness GC, et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 1993;85: 200-5.
14. Hong SI, Hong WS, Jang JJ, Lee DS, Cho NS, Jung ME, et al. Alterations of p53 gene in primary gastric cancer tissues. Anticancer Res 1994;14:1251-6.
15. Scarpa A, Capelli P, Mukai K, Zamboni G, Oda T, lacono C, et al. Pancreatic adenocarcinomas frequently show p53 gène mutations. Am J Pathol 1993;142:1534-43.
16. Baas IO, Mulder J-WR, Offerhaus GJA, Vogelstein B, Hamilton R. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994;172:5-12.
17. Kikuchi-Yanoshita R, Konishi M, Ito S, Seki M, Tanaka K, Maeda Y, et al. Genetical changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis. Cancer Res 1992;52: 3965-71.
18. Bertorelle R, Esposito G, Del Mistro A, Belluco C, Nitti D, Lise M, Chieco-Bianchi L. Association of p53 gene and protein alterations with métastases in colorectal cancer. Am J Surg Pathol 1995;19:463-71.
19. Banks L, Matlashewski G, Crawford L. Isolation of humanp53-specific monoclonal antibodies and their use in the studies ofp53 expression. EurJBiochem 1986;159:529-34.
20. Bartek J, Bartkova J, Vojtesek B, Staskova Z, Lukas J, Rejthar A, et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 1991;6:1699-703.
21. Shi S-R, Key ME, Kalra KL. Antigen retrieval in formalinfixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991 ; 39:741-8.
22. Cuevas EC, Bateman AC, Wilkins BS, Johnson PA, Williams JH, Lee AHS, et al. Microwave retrieval in immunohistochemistry: a study of antibodies. J Clin Pathol 1994; 47:448-52.
23. Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilbertson J, Foster C, et al. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991;51: 3497-502.
24. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain terminating inhibitors. ProcNatlAcadSci USA 1977; 74:5463-7.
25. Addison C, Jenkins JR, Sturzbecher HW. The p53 nuclear localization signal is structurally linked to a p34cdc2 kinase motif. Oncogene 1990;S:423-6.
26. Shaulsky G, Goldfinger N, Ben-Ze'Ve A, Rotter V. Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol CellBiol 1990;10:6565-77.
27. Carbone D, Chiba I, Mitsudomi T. Polymorphism at codon 213 within the p53 gene. Oncogene 1991;6:1691-2.
28. Hayashi K, Yandell DW. How sensitive is PCR-SSCP? Hum Mutât 1993;2:338-46.
29. Sheffield VC, Beck JS, Kwitek AE, Sandstrom AW, Stone EM. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 1993;16:325-32.
30. Hayashi K. PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl 1991;l:34-8.
31. Condie A, Eeles R, Borresen A-L, Coles C, Cooper C, Presser J. Detection of point mutations in the p53 gene: comparison of single-strand conformation polymorphism, constant dénaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques. Hum Mutât 1993;2:58-66.
32. Moyret C, Theillet C, Laurent-Puig P, Moles J-P, Thomas G, Hamelin R. Relative efficiency of denaturing gradient gel electrophoresis and single strand conformation polymorphism in the detection of mutations in exons 5 to 8 of the p53 gene. Oncogene 1994;9:1739-43.
33. Caron De Frommentel C, Soussi T. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosom Cancer 1992;4:1-15.
34. Greenblatt MS, Bennet WP, Hollstein M, Harris CG. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54: 4855-78.
35. Hartmann A, Blaszyk H, McGovern RM, Schroeder JJ, Cunningham J, De Vries EMG, et al. p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers. Oncogene 1995;10:681-8.
36. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992;69:1237-45.
37. Sheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papilloma virus type 16 and 18 promotes degradation of p53. Cell 1990;63:1129-36.
38. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991;351:453-6.
39. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAFl, a potential mediator of p53 tumor suppression. Cell 1993;775:817-25.
40. Lu X, Park SH, Thompson TC, Lane DP. ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation. Cell 1992;70:153-61.
41. Lane DP. The regulation of p53 function: Steiner Award Lecture. Int J Cancer 1994;57:623-7.
42. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992;356:215-21.